Search Results - "Burris, Thomas P."

REV-ERB and ROR nuclear receptors as drug targets.

Authors: Kojetin, Douglas J. Burris, Thomas P.

Source: Nature Reviews Drug Discovery. Mar2014, Vol. 13 Issue 3, p197-216. 20p. 6 Diagrams, 3 Charts, 1 Graph.

Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists.

Authors: Solt, Laura A. Wang, Yongjun Banerjee, Subhashis et al.

Source: Nature. 5/3/2012, Vol. 485 Issue 7396, p62-68. 7p.

Subjects: Circadian rhythms, Metabolic disorders, Cardiovascular system abnormality prevention, Skeletal muscle, Adipose tissues, Substance P, Laboratory mice, Chemical agonists

This result is not displayed to guests.
Login for full access.

Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand.

Authors: Solt, Laura A. Kumar, Naresh Nuhant, Philippe et al.

Source: Nature. 4/28/2011, Vol. 472 Issue 7344, p491-494. 4p. 4 Graphs.

Subjects: Interleukins, Nuclear receptors (Biochemistry), Cytokines, Autoimmune disease treatment, Acetamide, Cell differentiation, T-cell receptor genes, Therapeutics

Direct Regulation of CLOCK Expression by REV-ERB.

Authors: Crumbley, Christine Burris, Thomas P.

Source: PLoS ONE. 2011, Vol. 6 Issue 3, p1-6. 6p.

Structure of the intact PPAR-γ–RXR-α nuclear receptor complex on DNA.

Authors: Chandra, Vikas Huang, Pengxiang Hamuro, Yoshitomo et al.

Source: Nature. 11/20/2008, Vol. 456 Issue 7220, p350-356. 7p. 5 Diagrams.

Subjects: Molecular structure, Nuclear receptors (Biochemistry), Gene expression, Transcription factors, Ligand binding (Biochemistry), DNA-binding proteins, Peroxisomes, Scientific method

This result is not displayed to guests.
Login for full access.

A two-hit model of alcoholic liver disease that exhibits rapid, severe fibrosis.

Authors: Sengupta, Monideepa Abuirqeba, Suomia Kameric, Amina et al.

Source: PLoS ONE. 3/26/2021, Vol. 16 Issue 3, p1-17. 17p.

REV-ERB agonism improves liver pathology in a mouse model of NASH.

Authors: Griffett, Kristine Bedia-Diaz, Gonzalo Elgendy, Bahaa et al.

Source: PLoS ONE. 10/1/2020, Vol. 15 Issue 10, p1-14. 14p.

LXR-Mediated Inhibition of CD4⁺ T Helper Cells.

Authors: Solt, Laura A. Kamenecka, Theodore M. Burris, Thomas P. et al.

Source: PLoS ONE. Sep2012, Vol. 7 Issue 9, Special section p1-11. 11p.

Exercício Físico e Relógio Biológico: Uma revisão de literatura.

Authors: NUNES, R. S. M. VIEIRA, S. M. ALMEIDA, I. M. H. et al.

Source: Educação Física em Revista. 2017, Vol. 11 Issue 3, p9-18.

Rev-erbα heterozygosity produces a dose-dependent phenotypic advantage in mice.

Authors: Welch, Ryan D. Billon, Cyrielle Kameric, Amina et al.

Source: PLoS ONE. 5/14/2020, Vol. 15 Issue 5, p1-20. 20p.

Pharmacological activation of the nuclear receptor REV-ERB reverses cognitive deficits and reduces amyloid-β burden in a mouse model of Alzheimer’s disease.

Authors: Roby, Deborah A. Ruiz, Fernanda Kermath, Bailey A. et al.

Source: PLoS ONE. 4/12/2019, Vol. 14 Issue 4, p1-15. 15p.

Pharmacological Targeting the REV-ERBs in Sleep/Wake Regulation.

Authors: Amador, Ariadna Huitron-Resendiz, Salvador Roberts, Amanda J. et al.

Source: PLoS ONE. 9/7/2016, Vol. 11 Issue 9, p1-16. 16p.

Pharmacological and Genetic Modulation of REV-ERB Activity and Expression Affects Orexigenic Gene Expression.

Authors: Amador, Ariadna Wang, Yongjun Banerjee, Subhashis et al.

Source: PLoS ONE. 3/10/2016, Vol. 11 Issue 3, p1-12. 12p.

Artemisia scoparia Enhances Adipocyte Development and Endocrine Function In Vitro and Enhances Insulin Action In Vivo.

Authors: Richard, Allison J. Fuller, Scott Fedorcenco, Veaceslav et al.

Source: PLoS ONE. Jun2014, Vol. 9 Issue 6, p1-8. 8p.

Rev-erb-α modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy.

Authors: Woldt, Estelle Sebti, Yasmine Solt, Laura A et al.

Source: Nature Medicine. Aug2013, Vol. 19 Issue 8, p1039-1046. 8p. 6 Graphs.

Divergent transcriptional programming of class-specific B cell memory by T-bet and ROR?

Authors: Wang, Nathaniel S McHeyzer-Williams, Louise J Okitsu, Shinji L et al.

Source: Nature Immunology. Jun2012, Vol. 13 Issue 6, p604-611. 8p.

ZBTB32 restrains antibody responses to murine cytomegalovirus infections, but not other repetitive challenges.

Authors: Jash, Arijita Zhou, You W. Gerardo, Diana K. et al.

Source: Scientific Reports. 10/24/2019, Vol. 9 Issue 1, pN.PAG-N.PAG. 1p.

Correction: Pharmacological and Genetic Modulation of REV-ERB Activity and Expression Affects Orexigenic Gene Expression.

Authors: Amador, Ariadna Wang, Yongjun Banerjee, Subhashis et al.

Source: PLoS ONE. 5/19/2016, Vol. 11 Issue 5, p1-1. 1p.